These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38775688)
1. Role of NLRP3 Inflammasomes in Monocyte and Microglial Recruitments in Choroidal Neovascularization. Dieckmann BW; Paguaga ME; McCollum GW; Penn JS; Uddin MI Immunohorizons; 2024 May; 8(5):363-370. PubMed ID: 38775688 [TBL] [Abstract][Full Text] [Related]
2. Role of NLRP3 inflammasomes in monocyte and microglial recruitments in choroidal neovascularization. Dieckmann BW; Paguaga ME; McCollum GW; Penn JS; Uddin I Res Sq; 2023 Sep; ():. PubMed ID: 37720026 [TBL] [Abstract][Full Text] [Related]
3. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report. van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375 [TBL] [Abstract][Full Text] [Related]
4. Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization. Malsy J; Alvarado AC; Lamontagne JO; Strittmatter K; Marneros AG Elife; 2020 Dec; 9():. PubMed ID: 33305736 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death. Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823 [TBL] [Abstract][Full Text] [Related]
6. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model. Sui A; Chen X; Shen J; Demetriades AM; Yao Y; Yao Y; Zhu Y; Shen X; Xie B Cell Death Dis; 2020 Oct; 11(10):901. PubMed ID: 33093455 [TBL] [Abstract][Full Text] [Related]
7. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317 [TBL] [Abstract][Full Text] [Related]
8. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice. Ren P; Wu D; Appel R; Zhang L; Zhang C; Luo W; Robertson AAB; Cooper MA; Coselli JS; Milewicz DM; Shen YH; LeMaire SA J Am Heart Assoc; 2020 Apr; 9(7):e014044. PubMed ID: 32223388 [TBL] [Abstract][Full Text] [Related]
9. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy. Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320 [TBL] [Abstract][Full Text] [Related]
10. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages. Finucane OM; Sugrue J; Rubio-Araiz A; Guillot-Sestier MV; Lynch MA Sci Rep; 2019 Mar; 9(1):4034. PubMed ID: 30858427 [TBL] [Abstract][Full Text] [Related]
11. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice. Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408 [TBL] [Abstract][Full Text] [Related]
12. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo. Sui X; Yang J; Zhang G; Yuan X; Li W; Long J; Luo Y; Li Y; Wang Y Toxicology; 2020 Feb; 432():152392. PubMed ID: 32014472 [TBL] [Abstract][Full Text] [Related]
13. NLRP3 and Potassium Efflux Drive Rapid IL-1β Release from Primary Human Monocytes during Gov L; Schneider CA; Lima TS; Pandori W; Lodoen MB J Immunol; 2017 Oct; 199(8):2855-2864. PubMed ID: 28904126 [TBL] [Abstract][Full Text] [Related]
14. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction. Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609 [TBL] [Abstract][Full Text] [Related]
15. MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants. Schuh E; Groß CJ; Wagner D; Schlüter M; Groß O; Kümpfel T Clin Immunol; 2019 Jun; 203():45-52. PubMed ID: 30974290 [TBL] [Abstract][Full Text] [Related]
16. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. He W; Long T; Pan Q; Zhang S; Zhang Y; Zhang D; Qin G; Chen L; Zhou J J Neuroinflammation; 2019 Apr; 16(1):78. PubMed ID: 30971286 [TBL] [Abstract][Full Text] [Related]
17. The effects of NLRP3 inflammasome inhibition or knockout in experimental apical periodontitis induced in mice. Pucinelli CM; da Silva RAB; Nelson-Filho P; Lima RB; Lucisano MP; Marchesan JT; da Silva LAB Clin Oral Investig; 2024 Apr; 28(5):285. PubMed ID: 38684528 [TBL] [Abstract][Full Text] [Related]
18. NLRP3 regulates alveolar bone loss in ligature-induced periodontitis by promoting osteoclastic differentiation. Chen Y; Yang Q; Lv C; Chen Y; Zhao W; Li W; Chen H; Wang H; Sun W; Yuan H Cell Prolif; 2021 Feb; 54(2):e12973. PubMed ID: 33382502 [TBL] [Abstract][Full Text] [Related]
19. VEGF-production by CCR2-dependent macrophages contributes to laser-induced choroidal neovascularization. Krause TA; Alex AF; Engel DR; Kurts C; Eter N PLoS One; 2014; 9(4):e94313. PubMed ID: 24714223 [TBL] [Abstract][Full Text] [Related]
20. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation. Yaw ACK; Chan EWL; Yap JKY; Mai CW J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]